Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator.

about

Clinical safety, tolerability, pharmacokinetics and effects on urinary electrolyte excretion of AZD9977, a novel, selective mineralocorticoid receptor modulator.

Item

http://www.wikidata.org/entity/Q52690991

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinical safety, tolerability, ...... ocorticoid receptor modulator.

@en

Clinical safety, tolerability, ...... ocorticoid receptor modulator.

@nl

type

Item

label

Clinical safety, tolerability, ...... ocorticoid receptor modulator.

@en

Clinical safety, tolerability, ...... ocorticoid receptor modulator.

@nl

prefLabel

Clinical safety, tolerability, ...... ocorticoid receptor modulator.

@en

Clinical safety, tolerability, ...... ocorticoid receptor modulator.

@nl

P1476

Clinical safety, tolerability, ...... ocorticoid receptor modulator.

@en

P2093

Carl Amilon

http://www.w3.org/2001/XMLSchema#string

Hans Ericsson

http://www.w3.org/2001/XMLSchema#string

Judith Hartleib-Geschwindner

http://www.w3.org/2001/XMLSchema#string

Karin Nelander

http://www.w3.org/2001/XMLSchema#string

Krister Bamberg

http://www.w3.org/2001/XMLSchema#string

Ligia Chialda

http://www.w3.org/2001/XMLSchema#string

Linda Wernevik

http://www.w3.org/2001/XMLSchema#string

Magnus Kjaer

http://www.w3.org/2001/XMLSchema#string

Muna Albayaty

http://www.w3.org/2001/XMLSchema#string

P2860

Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators

Human plasma quantification of fludrocortisone using liquid chromatography coupled with atmospheric pressure chemical ionization mass spectrometry after low-dosage administration.

Effect of Finerenone on Albuminuria in Patients With Diabetic Nephropathy: A Randomized Clinical Trial.

Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

Pharmacokinetics of oral fludrocortisone in septic shock.

A systematic analysis of worldwide population-based data on the global burden of chronic kidney disease in 2010

The use of plasma aldosterone and urinary sodium to potassium ratio as translatable quantitative biomarkers of mineralocorticoid receptor antagonism.

Managing hyperkalemia caused by inhibitors of the renin-angiotensin-aldosterone system.

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.

P304

1486-1493

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/BCP.13562

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

R Jansson-Löfmark

Fredrik Erlandsson

P577

2018-02-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29468715

http://www.w3.org/2001/XMLSchema#string

P932

6005625

http://www.w3.org/2001/XMLSchema#string